Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10925977
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
granted -
US 10918666
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 2021038684
Compositions and Methods for Cancer Immunotherapy
granted -
US 10912797
Tumor infiltrating lymphocytes and methods of therapy
granted -
US 10905692
Combination therapy for treating malignancies
granted -
US 10905752
VEGFR-2 targeting DNA vaccine for combination therapy
granted -
US 10898585
Gene therapy for AADC deficiency
granted -
US 10898595
Core-satellite nanocomposites for MRI and photothermal therapy
granted -
US 2021015826
ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
granted -
US 10894063
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10894044
Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer
granted -
US 10889817
Oligonucleotide therapy for Leber Congenital Amaurosis
granted -
US 10876134
Gene therapy for juvenile batten disease
granted -
US 10874633
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted -
LT 3254695
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
granted -
US 10870837
Fusion proteins comprising enzyme replacement therapy enzymes
granted -
US 10864217
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
granted -
US 10849885
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
granted -
US 10844090
Hemiasterlin derivatives for conjugation and therapy
granted -
US 10835595
PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy
granted -
US 10835604
Biomaterials for combined radiotherapy and immunotherapy of cancer
granted -
US 10821117
Estrogen therapy for brain gray matter atrophy and associated disability
granted -
US 10821163
Process for the production of a DNA vaccine for cancer immunotherapy
granted -
US 10815455
Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
granted